Global Pharmaceutical Blister Packaging Market Size, Share, and COVID-19 Impact Analysis, By Material (Plastic, Aluminium Foil, and Paper), By Technology (Cold Forming, Thermoforming, and Heat Seal), By Application (Tablets, Capsules, Oral Thin Films & Lozenges, and Diagnostic Kits & Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Pharmaceutical Blister Packaging Market Insights Forecasts to 2035

• The Global Pharmaceutical Blister Packaging Market Size Was Estimated at USD 21.75 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.08% from 2025 to 2035
• The Worldwide Pharmaceutical Blister Packaging Market Size is Expected to Reach USD 46.15 Billion by 2035
• Asia Pacific is Expected to Grow the Fastest during the forecast period.

The Global Pharmaceutical Blister Packaging Market Size was worth around USD 21.75 Billion in 2024 and is predicted to grow to around USD 46.15 Billion by 2035 with a compound annual growth rate (CAGR) of 7.08% from 2025 to 2035. The versatility, cost-effectiveness, and high-barrier properties of blister packaging, along with an expanding healthcare sector, are driving the blister packaging market worldwide.  

Market Overview

The pharmaceutical blister packaging market is a market that emphasizes the production and supply of blister packs for pharmaceutical products. Pharmaceutical blister packaging is a type of healthcare packaging that protects the medicine from moisture and contamination, ensuring safety even after opening. With the evolving consumer needs, the global market is transforming, driven by stringent regulatory requirements and packaging technology advancements. Technological advancements and innovative solutions are addressing sustainability concerns, aligning with eco-friendly packaging trends, which is escalating the market growth for pharmaceutical blister packaging. Customized blister pharmaceutical packaging is being designed to meet a wide range of medicine requirements by seamlessly integrating functionality, sustainability, and design precision to deliver results that align perfectly with the need. Companies are increasingly emphasizing the introduction of sustainable packaging products using dry molded fiber technology, which minimizes CO₂ emissions and can be recycled like paper, which is driven by collaborative efforts to reduce single-use plastic packaging. Designing of hybrid boxes, which include blister packaging and additional compartments for drug delivery, such as inhalers, transdermal patches, and syringes, is escalating the market opportunities for pharmaceutical blister packaging.

Report Coverage

This research report categorizes the pharmaceutical blister packaging market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the pharmaceutical blister packaging market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the pharmaceutical blister packaging market.

Driving Factors

An introduction of sustainable & regulatory compliant blister packaging solutions, along with the increasing prevalence of chronic diseases, is significantly contributing to driving the pharmaceutical blister packaging market. The advancements in cold-form foil technology to enhance drug protection aid in propelling the market growth. There is an increasing popularity of blister packaging in the pharmaceutical sector as pharmaceutical packaging machine manufacturers are looking for solutions with heightened protection against oxygen, moisture, and contaminants, which results in propelling the market growth.

Restraining Factors

The impact of economic slowdowns on pharmaceutical packaging investments is challenging the pharmaceutical blister packaging market. The growing rate of medical waste and upsurging environmental concerns & regulatory pressures are limiting packaging adoption, thereby hampering the market growth.

Market Segmentation

The pharmaceutical blister packaging market share is classified into material, technology, and application.

• The plastic segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the material, the pharmaceutical blister packaging market is divided into plastic, aluminium foil, and paper. Among these, the plastic segment dominated the market with the largest share in 2024 and is projected to grow at a substantial CAGR during the forecast period. The compact size and lightweight property of plastic-based blister packaging, as compared to cold-formed aluminum, is responsible for driving the market in the plastic segment.

• The thermoforming segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the technology, the pharmaceutical blister packaging market is divided into cold forming, thermoforming, and heat seal. Among these, the thermoforming segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Thermoforming blister packaging is the most common and effective method used by pharmaceutical companies. The faster production speeds and lower manufacturing costs of thermoforming technology are responsible for driving the pharmaceutical blister packaging market.

• The tablets segment accounted for the largest share of the pharmaceutical blister packaging market in 2024 and is anticipated to grow at a significant CAGR during the forecast period.

Based on the application, the pharmaceutical blister packaging market is divided into tablets, capsules, oral thin films & lozenges, and diagnostic kits & others. Among these, the tablets segment accounted for the largest share of the pharmaceutical blister packaging market in 2024 and is anticipated to grow at a significant CAGR during the forecast period. Blister packaging is the commonly used unit dose packaging for pharmaceutical tablets, which provides barrier protection for shelf life requirements and a degree of tamper resistance. The global rise in oral pharmaceutical product consumption is responsible for driving the market demand in the tablets segment.

Regional Segment Analysis of the Pharmaceutical Blister Packaging Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the pharmaceutical blister packaging market over the predicted timeframe.

North America is anticipated to hold the largest share of the pharmaceutical blister packaging market over the predicted timeframe. An increasing prevalence of diseases, as well as new product innovations including the use of sustainable materials, are contributing to promoting the pharmaceutical blister packaging market. Further, the growing usage of blister packages and increasing sales of over-the-counter drugs aid in driving the market demand.

Asia Pacific is expected to grow at a rapid CAGR in the pharmaceutical blister packaging market during the forecast period. An increasing need for maintaining product integrity and extended shelf life in the pharmaceutical sector is driving the market demand for pharmaceutical blister packaging. The region’s expanding pharmaceutical sector, along with the increasing awareness about safe and effective drug packaging, is contributing to propelling the market.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the pharmaceutical blister packaging market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Amcor plc
• Smurfit Westrock
• Constantia Flexibles
• Sonoco Products Company
• Huhtamaki Oyj
• Tekni-Plex Inc.
• ACG Pharmapack
• Aptar CSP Technologies
• Klockner Pentaplast
• Perlen Packaging
• Honeywell International (Aclar Films)
• Bilcare Research
• Bemis Healthcare (now Amcor Flexibles)
• Uhlmann Packaging Systems
• IMA Group
• Syntegon Technology
• Marchesini Group
• Romaco Group
• PharmaWorks (ProMach)
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs) 

Recent Development

• In November 2024, Switzerland-based Bayer launched polyethylene terephthalate (PET) blister packaging on its healthcare brand, Aleve, calling it a first-of-its-kind product in the healthcare industry.

• In October 2024, Uhlmann India marks the inauguration of its new office and hosts an in-house event with industry leaders, partners, and customers, highlighting advancements in blister packaging technology and localisation efforts.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the pharmaceutical blister packaging market based on the below-mentioned segments: 

Global Pharmaceutical Blister Packaging Market, By Material

• Plastic
• Aluminium Foil
• Paper

Global Pharmaceutical Blister Packaging Market, By Technology

• Cold Forming
• Thermoforming
• Heat Seal

Global Pharmaceutical Blister Packaging Market, By Application

• Tablets
• Capsules
• Oral Thin Films & Lozenges
• Diagnostic Kits & Others

Global Pharmaceutical Blister Packaging Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa